Luisa M Stamm, MD, PhD

home / authors / luisa-m-stamm-md-phd

Associate Vice President of Infectious Disease Clinical Research and Section Head for HIV at Merck.

Articles

Merck Presents HIV Prevention and Treatment Portfolio at IAS 2025 with Focus on Once-Monthly PrEP

Merck Presents HIV Prevention and Treatment Portfolio at IAS 2025 with Focus on Once-Monthly PrEP

Luisa M Stamm, MD, PhD;Sophia Abene
July 18th 2025

Luisa M Stamm, MD, PhD, further discusses MK-8527 and islatravir-based regimens in HIV research.

Read More

Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention

Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention

Sophia Abene;Luisa M Stamm, MD, PhD
July 15th 2025

At IAS 2025, Luisa Stamm, MD, PhD, explains the NRTTI’s mechanism, study setup, and key data on HIV prevention efforts.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention
Published: July 15th 2025 | Updated: July 21st 2025
Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention
TAXIS Pharmaceuticals Earns FDA QIDP Designation for Its Efflux Pump Inhibitor for Pneumonia
Published: July 15th 2025 | Updated: July 21st 2025
TAXIS Pharmaceuticals Earns FDA QIDP Designation for Its Efflux Pump Inhibitor for Pneumonia
Study Results Find AMR Policy Messaging Misses the Mark With Agricultural Stakeholders
Published: July 15th 2025 | Updated: July 21st 2025
Study Results Find AMR Policy Messaging Misses the Mark With Agricultural Stakeholders
FDA Approves Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention
Published: July 17th 2025 | Updated: July 21st 2025
FDA Approves Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention
Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing
Published: July 15th 2025 | Updated: July 21st 2025
Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing
© 2025 MJH Life Sciences

All rights reserved.